Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Benchmark Bullish On Hub Group, Sees 30% Upside

Benchmark analyst Christopher Kuhn initiated coverage of Hub Group Inc (NASDAQ:HUBG) with a Buy rating and a price target of $90, implying an upside of 31%. According to the analyst, intermodal volume growth will turn positive in 2022. Kuhn anticipates growth to continue in 2022, but he sees margins normalizing in 2023 as pricing…

4 Analysts Have This to Say About Centessa Pharmaceuticals

4 Analysts Have This to Say About Centessa Pharmaceuticals

Analysts have provided the following ratings for Centessa Pharmaceuticals (NASDAQ:CNTA) within the last quarter:

Where Urban Outfitters Stands With Analysts

Where Urban Outfitters Stands With Analysts

Within the last quarter, Urban Outfitters (NASDAQ:URBN) has observed the following analyst ratings:

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

What To Watch For On Advanced Micro Devices Stock As It Continues In This Trend

Advanced Micro Devices, Inc. (NASDAQ: AMD) plunged more than 8% on Thursday and was trading slightly higher when the markets opened on Friday.

VYNE Therapeutics Concludes Patient Enrolment in Mid-Stage Study Of Skin Inflammation Candidate

VYNE Therapeutics Inc. (NASDAQ: VYNE) has concluded patient enrollment in the Phase 2a study of of its drug candidate FMX114 for the treatment of mild-to-moderate atopic dermatitis (AD).

Final Draft Of Macau Gaming Law: What Investors Need To Know

The Macau Legislative Assembly signed the final draft of the new Macau gaming law this week. Bank of America analyst Billy Ng says there's nothing in the legislation that dampens his long-term bullish thesis on the Macau gaming market. Draft Updates: The final draft of the law includes the following…

Why Shares Of Addex Therapeutics Are Falling Today

Shares of small-cap penny stock Addex Therapeutics Ltd. (NASDAQ: ADXN) are trading lower after the company terminated its Phase 2b/3 study of Dipraglurant for dyskinesia associated with Parkinson's disease due to slow recruitment. The company suspended its guidance amid the termination.

inkl

Read news from The Economist, FT, and more,
with one subscription

Why Mereo BioPharma Shares Are Jumping Today

Why Mereo BioPharma Shares Are Jumping Today

AstraZeneca plc (NASDAQ:AZN) is rumored to be eyeing take over of Mereo BioPharma Group plc (NASDAQ:MREO), according to a report in The Times. The Times' report says that "Mereo would accept $5, equating to $500 million including American depositary receipts or ADRs. Evercore and Citigroup are said to be involved as advisers." Mereo's lead…

Allegiant Travel Clocks ~17% Growth In May Capacity

Allegiant Travel Clocks ~17% Growth In May Capacity

Allegiant Travel Company (NASDAQ:ALGT) May 2022 Scheduled Service capacity grew by ~16% and completed the month with a load factor of 87%, up 3.0pts, compared to 2019 numbers. "The average cost per fuel gallon in May was $4.41 and we now expect to finish the quarter at an average cost per gallon…

Why Shares Of ToughBuilt Industries Are Tanking Today

Why Shares Of ToughBuilt Industries Are Tanking Today

Shares of small-cap penny stock ToughBuilt Industries, Inc. (NASDAQ: TBLT) are trading lower after the company priced a $6 million offering.

U.S. Markets Open Higher; Dow Rises Around 200 Points

U.S. Markets Open Higher; Dow Rises Around 200 Points

U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Friday.

Monro Completes Sale Of Tires Now Assets To American Tire Distributors

Monro Completes Sale Of Tires Now Assets To American Tire Distributors

Monro Inc (NASDAQ:MNRO) has completed the previously-announced sale of its wholesale tire and distribution assets to American Tire Distributors (ATD). The company sold its Tires Now distribution assets for $105 million in cash. Monro's wholesale tire locations included seven facilities in Kentucky, North Carolina, South Carolina, and Tennessee which serviced more than 3,500 wholesale customer…

TikTok President Reasons Why Copying The Former Will Not Be Conducive For Facebook

TikTok President Reasons Why Copying The Former Will Not Be Conducive For Facebook

TikTok's President of Global Business Solutions and former Meta Platforms, Inc (NASDAQ:META) Facebook veteran Blake Chandlee in a CNBC interview, shared how TikTok massively differed from Facebook. ByteDance Ltd-owned TikTok did not look to mimic Facebook. In contrast, Facebook struggled to win users by restructuring its Facebook and Instagram apps to emulate TikTok's popular short video format.…

Jim Cramer Recommends Buying This Stock

Jim Cramer Recommends Buying This Stock

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Terran Orbital Corp (NASDAQ: LLAP) is one of those "newer companies that doesn’t have any earnings."

Get all your
news in one place.

100’s of premium titles.
One news app.

Here's Why Aurora Mobile Shares Are Trading Higher Premarket

Shenzhen Development and Reform Commission granted a special support funding of RMB15 million to Aurora Mobile Limited (NASDAQ:JG) under the Strategic Emerging Industries Development Program. Aurora Mobile's deep learning related project had completed the acceptance test from the Commission. Aurora Mobile is a leading provider of customer engagement and marketing technology services in China.…

Benzinga Before The Bell: SpaceX Fires Staff Critical Of Musk, Snapchat Tests Subscriptions And Other Top Financial Stories Friday, June 17

Reuters London’s Gatwick Airport To Fly Lesser Number Of Flights During Summer Season

3 Stocks Under $5 Insiders Are Aggressively Buying

U.S. stocks closed sharply lower, with the Nasdaq Composite dipping around 450 on Thursday. Investors, meanwhile, focused on some notable insider trades.

Whole Earth Brands Boosts Credit Facility

Whole Earth Brands Inc (NASDAQ:FREE) has completed an amendment, effective June 15, 2022, to its amended and restated credit agreement with its lenders. The agreement reflects a $50 million increase in the company's revolving credit facility from $75 million to $125 million. The agreement also replaces LIBOR with SOFR as the reference interest…

Get all your
news in one place.

100’s of premium titles.
One news app.

Elon Musk's Twitter Takeover Could Address Crypto Scams, Usher In Bitcoin, Dogecoin Payments

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk addressed cryptocurrency scams and payments in his interaction with Twitter Inc (NYSE: TWTR) employees Thursday.

GM Backed Cruise Is Giving Google, Tesla A Run For Their Money

General Motors Company (NYSE: GM) backed Cruise offered tough competition to Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) Google in the

Twitter And 2 Other Stocks Insiders Are Selling

US stock futures traded higher this morning on Friday after recording sharp losses in the previous session. Investors, meanwhile, focused on some notable insider trades.

HEXO Acknowledges Zenabis Group CCAA Filing

HEXO Corp. (NASDAQ: HEXO) (TSX:HEXO) acknowledged that its wholly-owned subsidiary, Zenabis Global Inc., as well as Zenabis’ direct and indirect wholly-owned subsidiaries, have filed a petition with the Superior Court of Québec<

Insiders Buy More Than $20M Of 3 Stocks

Although the Dow Jones dropped more than 700 points on Thursday, there were a few notable insider trades.

Addex Stops Parkinson's-Associated Dyskinesia Trial - Read Here Why

Addex Therapeutics Ltd (NASDAQ:ADXN) has terminated the Phase 2b/3 study of dipraglurant for dyskinesia associated with Parkinson's disease (PD-LID) due to the slow recruitment of patients. Data readout from the trial was expected in 1H of 2023. The company attributes this to the consequences of COVID-19-related patient concerns about participation in studies, staffing…

LAVA Therapeutics Highlights Encouraging Clinical Updates on Lead Cancer Program

LAVA Therapeutics N.V. (NASDAQ:LVTX) hosted a clinical update call focused on initial Phase 1/2a data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) at the American Society of Clinical Oncology and European Hematology Association meetings. "Although preliminary, these data support our view of LAVA-051 as a promising candidate…

1 … 348 349 350 351

People

Mark Zuckerberg

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Bank of America

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Social Networking

Places

319,018 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play